Selectivity index, ratio of CC50 for HIV1 human TZM-bl cells to EC50 for HIV1 ENV pseudotype from the lab-adapted CXCR4-tropic HIV-1 HXB-2 infected in human TZM-bl cells
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env Q259ENV.W6 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env QB726.70M.ENV.C4 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env QF495.23M.ENV.A1 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env QF495.23M.ENV.A3 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env BG505-T332N infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env KNH1144 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env QA790.2041.ENV.A4 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env QA790.2041.ENV.E2 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env QG393.60M.ENV.A1 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env QG393.60M.ENV.B7 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env CRF02_AG Clone 211 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env CRF02_AG Clone 250 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env CRF02_AG Clone 251 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env CRF02_AG Clone 255 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env CRF02_AG Clone 257 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env CRF02_AG Clone 258 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env CRF02_AG Clone 266 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay
Antiviral activity against pseudovirus HIV-1 HXB-2 subtype A pseudotyped Env CRF02_AG Clone 269 infected in human U87.CD4.CXCR4 cells assessed as reduction in viral infection measured after 3 days by luciferase based assay